Xencor Inc (NASDAQ:XNCR)
| 20.24 Delayed Data As of Dec 08 |  +0.03 / +0.15%Today’s Change | 16.49 Today|||52-Week Range 38.20 | -22.27% Year-to-Date |
Latest XNCR News | Press Releases
No recent news for Xencor Inc.
Today’s Trading
| Previous close | 20.21 |
| Today’s open | 20.16 |
| Day’s range | 19.95 - 20.52 |
| Volume | 23,548 |
| Average volume (3 months) | 371,122 |
| Market cap | $1.2B |
Data as of 4:00pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | -165.35% |
| Earnings growth (this year) | -259.43% |
| Earnings growth (next 5 years) | +74.10% |
| Revenue growth (last year) | -40.18% |
| P/E ratio | NM |
| Price/Sales | 9.44 |
| Price/Book | 1.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RAPTRAPT Therapeutics In... | -0.03 | -0.17% |
| MORFMorphic Holding Inc | +0.58 | +2.18% |
| ---- | ||
| BCYCBicycle Therapeutics... | +0.10 | +0.64% |
Data as of 3:59pm ET, 12/08/2023
Financials
| Next reporting date | February 26, 2024 |
| EPS forecast (this quarter) | -$0.66 |
| Annual revenue (last year) | $164.6M |
| Annual profit (last year) | -$55.2M |
| Net profit margin | -33.53% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Monrovia, California |
Forecasts
